Barriga, Danver Kayle .

HRN: 23-82-24  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2025
CEFUROXIME 1.5GM (VIAL)
11/06/2025
11/13/2025
IV DRIP
375mg
Q8
Acute Respiratory Tract Infection
Waiting Final Action 
11/09/2025
CEFTRIAXONE 1G (VIAL)
11/09/2025
11/16/2025
IV
560mg
Q12
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: